EACR-23 will build on the success of the previous congress which was widely praised for the quality of its programme and inspirational contributions. The EACR Congress has grown rapidly in recent years and we expect around 1,800 scientists working in all fields of cancer research to come together to discuss the latest developments in basic and discovery driven translational research, through to personalised cancer treatment.